Cell-free DNA monitoring in a phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor ribociclib for localized HR+/HER2-breast cancer (LEADER)Arielle J. Medford,Lauren Scarpetti,Andrzej Niemierko,Steven J. Isakoff,Beverly Moy,Seth A. Wander, Elizabeth Deluca,Elizabeth Abraham,Jennifer Shin,Lowell Schnipper,Amy E. Comander,Therese Mulvey,Erik Spickard,Ekaterina Kalashnikova,Angel Rodriguez,Leif Ellisen,Aditya Bardia,Laura M. SpringCANCER RESEARCH（2023）引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
